U.S. flag An official website of the United States government
  1. Home
  2. Animal & Veterinary
  3. News & Events
  4. CVM Updates
  5. FDA Accepting Proposals for FY 2024-2025 Funding Opportunities to Collect Data on Antimicrobial Use in Animals
  1. CVM Updates

FDA Accepting Proposals for FY 2024-2025 Funding Opportunities to Collect Data on Antimicrobial Use in Animals

March 5, 2024

The U.S. Food and Drug Administration is accepting proposals through May 13, 2024 for cooperative agreement funding to support the collection of antimicrobial use data from diverse animal sectors. The cooperative agreements provide up to three awards in fiscal year (FY) 2024 for a total of $600,000, and up to five awards in FY 2025 for a total of $1,000,000. The funding opportunities are the FDA’s latest step toward collecting information about the use of antimicrobials in animals.

The FDA will prioritize allocating the FY 2024 funds to proposals that specifically target collecting data about use of antimicrobials in cattle, swine, chickens and turkeys. The agency encourages applicants with proposals targeting data collection in companion animal and minor species to apply in FY 2025. 

Each FY 2024 award would provide one year of support up to $200,000 and may lead to additional support for up to four additional years, contingent upon recipient performance, annual appropriations, and availability of funding. Additional details are available in the grants.gov notice.

Antimicrobial use data collection projects funded under this Notice of Funding Opportunity would collect data in a manner similar to that envisioned for the "data partners" outlined in a report compiled for the FDA by the Reagan-Udall Foundation. Funding recipients would be expected to contribute to the development of data collection frameworks, including providing data and expertise towards developing a data repository as resources and public-private partnership framework becomes available.

Through this funding opportunity, the agency hopes to build upon the FDA’s ongoing efforts to better understand antimicrobial use in the U.S. and improve antimicrobial stewardship in animals. The FDA believes it is important to support new and ongoing efforts to collect antimicrobial use data in various veterinary sectors as the agency continues to further develop a broader public-private partnership model to collect and analyze antimicrobial use data, such as outlined in the Reagan Udall report. To learn more about what the FDA has done in this area, see: Antimicrobial Animal Drug Use Data.

Additional Information

Issued by FDA Center for Veterinary Medicine.
For questions, Contact CVM.

Back to Top